Determining Kinases Inhibition by Anti-malarial Compounds
Closed Solicitation Posted
- Solicitation number
- 75N95022Q00553
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- Q301 Reference Laboratory Testing
Notice details come from SAM.gov. Updated .
Notice text
The National Center for Advancing Translational Sciences (NCATS) requires contractor results of profiling malaria compounds against a panel of human kinases for 4500 data points at one concentration and 300 IC50 curves. It is important to measure NCATS compounds’ activity against human lipid kinases so that a strategy can be developed to keep the malaria parasites killing activity and remove/reduce the human lipid kinase inhibitory activities.
Files
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity